小分子靶点筛选 > Pull down筛靶策略
pull down.png
  • pull down.png

Pull down筛靶策略

小分子药靶筛选的Pull down实验是一种有效的筛选药物与潜在靶蛋白之间相互作用的体外技术,Pull down实验基本原理是将小分子药物固定在某种基质上,充当“钓饵”,与蛋白裂解液进行孵育,孵育结束后与化合物结合的蛋白可以通过对基质的分离而分离出来。该方法简单易行,操作方便,在药靶筛选方面已得到广泛的应用。

Pull down技术是一种有效的筛选药物与潜在靶蛋白之间相互作用的体外技术。利用生物分子之间的亲和力原理,将生物素标记的小分子药物作为“诱饵”固定玉链霉亲和素的磁珠,再从细胞裂解液中“钓取”并富集与之特异性结合的靶点蛋白,随后通过质谱进行药物结合靶蛋白鉴定。

图1:Pull down 原理(1).jpg

技术优势

1. 基于亲和捕获策略,适用于多类型小分子靶点的富集筛选

2. 在靶细胞/靶组织中进行筛选,靶点的细胞/组织特异性强

3. 高效富集结合蛋白,获得较全面的候选靶点谱

客户案例

案例1:绿原酸靶向RAC1缓解系膜增生性肾小球肾炎

中国人民解放军总医院(301医院)陈香美院士团队在《Acta Pharmaceutica Sinica B》发表题为“Direct pharmacological targeting of RAC1 by chlorogenic acid: A novel therapeutic approach for mesangial proliferative glomerulonephritis”研究成果。研究发现,绿原酸能够直接结合小GTP酶RAC1,抑制RAC1-AKT-THBS1-CD36信号轴活化,从而抑制系膜细胞异常增殖并减轻炎症反应,为MsPGN治疗提供了新的分子机制依据。(达吉特为该研究提供了绿原酸小分子标记和Pull-down+MS靶点筛选服务)

案例:pull down-绿原酸.jpg

案例2:黄芪来源纳米颗粒通过靶向TLR2增强乳腺癌化疗效果

南京中医药大学团队在《Acta Pharmacologica Sinica B》发表题为“Astragalus-derived nano-agonist potentiates chemotherapy by reducing tumor-suppressive macrophages”的研究论文。本研究首次证实黄芪源外泌体样纳米颗粒(ADNPs)通过其所释放的芒柄花素发挥功效。随后利用生物素标记的芒柄花素进行Pull down筛选,发现其直接靶点TLR2,揭示了ADNPs重编程肿瘤巨噬细胞、增强顺铂化疗疗效,同时缓解骨髓抑制的分子机制。(达吉特为该研究提供了小分子生物素标记与Pull down+MS筛靶服务)

案例2:pull down-黄芪来源纳米颗粒.jpg

客户文献

  1. Xu Q, Li G, Zhang H, et al. The natural flavonoid dihydromyricetin targets senescent cells via PRDX2 and alleviates age-related diseases. Nat Commun. Published online March 6, 2026. doi:10.1038/s41467-026-70302-9

  2. Qu Y, Wu L, Wang Y,, et al. Direct pharmacological targeting of RAC1 by chlorogenic acid: A novel therapeutic approach for mesangial proliferative glomerulonephritis, Acta Pharmaceutica Sinica B, https://doi.org/10.1016/ j.apsb.2026.06.041.

  3. Han X, Yang YB, Lu QW, et al. Astragalus-derived nano-agonist potentiates chemotherapy by reducing tumor-suppressive macrophages. Acta Pharm Sin B. 2026, ISSN 2211-3835. doi.org/10.1016/j.apsb.2026.03.051.

  4. Liu J, Ren Z, Sun Y, et al. Investigation of the Relationship between Aptamers' Targeting Functions and Human Plasma Proteins. ACS Nano. 2023;17(23):24329-24342. doi:10.1021/acsnano.3c10238

  5. Han RY, Tan RZ, Xu LH, et al. Activation of sclerostin inhibits Isg20-Mediated aerobic glycolysis ameliorating renal Fibrosis: the renoprotective mechanism of hederagenin in CKD. Redox Biol. Published online July 8, 2025. doi:10.1016/j.redox.2025.103762

  6. Su T, Shi Z, Tan J, et al. Casticin activates Rheb GTPase by binding to residue Trp141 and induces tumor senescence. Pharmacol Res. 2025;218:107855. doi:10.1016/j.phrs.2025.107855

  7. Deng Y, Zeng X, Lv Y, et al. Cdyl2-60aa encoded by CircCDYL2 accelerates cardiomyocyte death by blocking APAF1 ubiquitination in rats. Exp Mol Med. 2023;55(4):860-869. doi:10.1038/s12276-023-00983-5

  8. Liang HX, Yuan ZY, Liu RM, et al. Ginkgetin alleviates sepsis-induced acute lung injury by promoting autophagy via inhibiting ubiquitination of Laptm5 in macrophages. Phytomedicine. 2026;153:157894. doi.org/10.1016/j.phymed.2026.157894.

  9. Ai S, Tao J, Wang Y, et al. Paeonol ameliorates diabetic nephropathy by promoting TFEB-mediated lysosome biogenesis and lipophagy. Phytomedicine. 2025 Jul 25;143:156901. doi: 10.1016/j.phymed.2025.156901. Epub 2025 May 24. PMID: 40466504.